Mr. Zohar Krivorot reports

CANNARA BIOTECH ANNOUNCES APPOINTMENT OF JUSTIN COHEN TO BOARD OF DIRECTORS

Cannara Biotech Inc. has appointed Justin Cohen to its board of directors as an independent director. Mr. Cohen will also serve as a member of the audit committee.

Mr. Cohen is a seasoned executive with a record of driving transformational growth and providing valuable leadership in brand development, sales and marketing. As chief marketing and chief commercial officer at Psycho Bunny, he spearheaded the brand's evolution from a niche player to a global powerhouse. Under his leadership, revenues increased tenfold over three years, driven by strategic retail expansion, digital acceleration and brand reinvention.

Prior to Psycho Bunny, Mr. Cohen led direct-to-consumer and e-commerce strategy at Keurig Dr. Pepper, expanding its digital footprint and scaling revenue across on-line and omnichannel platforms. He has also held leadership roles at Google, Aldo Group and Sony Music, where he guided brands through digital transformation and new growth opportunities.

Currently, as a senior executive at Cosmetic Physician Partners, Mr. Cohen oversees integrated marketing across a portfolio of over 55 clinics in the United States, ensuring scalable and sustainable expansion. In addition to his corporate leadership, he serves on the board of Dose Juice, advising on commercial strategy, market expansion and operational efficiency. Mr. Cohen holds degrees in marketing and advertising, an MBA, and a master in behavioural science from the London School of Economics.

"We are thrilled to welcome Justin to our board," said Zohar Krivorot, chief executive officer of Cannara. "His expertise in brand building, digital transformation and consumer engagement aligns perfectly with Cannara's vision to execute our strategy of positioning our three flagship brands -- Tribal, Nugz and Orchid CBD -- as Canada's leading cannabis brands. His strategic leadership will be invaluable as we scale our operations and expand our brand equity and market presence in Canada."

"I am honoured to join Cannara's board of directors at such an exciting time," said Mr. Cohen. "Cannara has established itself as a leader in the cannabis industry with a strong commitment to quality, innovation and accessibility. I look forward to contributing my experience in brand strategy and digital transformation to support Cannara's continued success and expansion."

About Cannara Biotech Inc.

Cannara is a vertically integrated producer of affordable premium-grade cannabis and cannabis-derivative products for the Canadian markets. Cannara owns two megafacilities based in Quebec spanning over 1.65 million square feet, providing the company with 100,000 kilograms of potential annualized cultivation output. Leveraging Quebec's low electricity costs, Cannara's facilities produce premium-grade cannabis products at an affordable price.

We seek Safe Harbor.